Gori S - Search Results

1

Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancer.

Tarantini L, Cioffi G, Gori S, Tuccia F, Boccardi L, Bovelli D, Lestuzzi C, Maurea N, Oliva S, Russo G, Faggiano P; Italian Cardio-Oncologic Network. Tarantini L, et al. Among authors: gori s. J Card Fail. 2012 Feb;18(2):113-9. doi: 10.1016/j.cardfail.2011.10.015. Epub 2011 Dec 3. J Card Fail. 2012. PMID: 22300778

2

Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer.

Gori S, Colozza M, Mosconi AM, Franceschi E, Basurto C, Cherubini R, Sidoni A, Rulli A, Bisacci C, De Angelis V, Crinò L, Tonato M. Gori S, et al. Br J Cancer. 2004 Jan 12;90(1):36-40. doi: 10.1038/sj.bjc.6601485. Br J Cancer. 2004. PMID: 14710203 Free PMC article. Clinical Trial.

3

Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trial.

Nuzzo F, Morabito A, De Maio E, Di Rella F, Gravina A, Labonia V, Landi G, Pacilio C, Piccirillo MC, Rossi E, D'Aiuto G, Thomas R, Gori S, Colozza M, De Placido S, Lauria R, Signoriello G, Gallo C, Perrone F, de Matteis A. Nuzzo F, et al. Among authors: gori s. Crit Rev Oncol Hematol. 2008 May;66(2):171-80. doi: 10.1016/j.critrevonc.2007.10.006. Epub 2007 Dec 21. Crit Rev Oncol Hematol. 2008. PMID: 18160303 Clinical Trial.

4

Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine.

Metro G, Foglietta J, Russillo M, Stocchi L, Vidiri A, Giannarelli D, Crinò L, Papaldo P, Mottolese M, Cognetti F, Fabi A, Gori S. Metro G, et al. Among authors: gori s. Ann Oncol. 2011 Mar;22(3):625-630. doi: 10.1093/annonc/mdq434. Epub 2010 Aug 19. Ann Oncol. 2011. PMID: 20724575 Free article.

5

HER-3 status by immunohistochemistry in HER-2-positive metastatic breast cancer patients treated with trastuzumab: correlation with clinical outcome.

Gori S, Foglietta J, Mameli MG, Stocchi L, Fenocchio D, Anastasi P, Iacono D, Del Sordo R, Basurto C, De Angelis V, Sidoni A. Gori S, et al. Tumori. 2012 Jan-Feb;98(1):39-44. doi: 10.1177/030089161209800105. Tumori. 2012. PMID: 22495700

6

Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study.

Gori S, Clavarezza M, Siena S, Foglietta J, Tarenzi E, Giordano M, Molino A, Graiff C, Fusco V, Alabiso O, Baldini E, Gamucci T, Altavilla G, Dondi D, Venturini M. Gori S, et al. BMC Cancer. 2012 Apr 30;12:158. doi: 10.1186/1471-2407-12-158. BMC Cancer. 2012. PMID: 22545982 Free PMC article.

7

Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study.

Clavarezza M, Mustacchi G, Casadei Gardini A, Del Mastro L, De Matteis A, Riccardi F, Adamo V, Aitini E, Amoroso D, Marchetti P, Gori S, Carrozza F, Maiello E, Giotta F, Dondi D, Venturini M. Clavarezza M, et al. Among authors: gori s. BMC Cancer. 2012 Jun 6;12:216. doi: 10.1186/1471-2407-12-216. BMC Cancer. 2012. PMID: 22672524 Free PMC article.

8

Adjuvant trastuzumab cardiotoxicity in patients over 60 years of age with early breast cancer: a multicenter cohort analysis.

Tarantini L, Gori S, Faggiano P, Pulignano G, Simoncini E, Tuccia F, Ceccherini R, Bovelli D, Lestuzzi C, Cioffi G; ICARO (Italian CARdio-Oncologic) Network. Tarantini L, et al. Among authors: gori s. Ann Oncol. 2012 Dec;23(12):3058-3063. doi: 10.1093/annonc/mds127. Epub 2012 Jun 13. Ann Oncol. 2012. PMID: 22700991 Free article.

9

Role of renal function on the development of cardiotoxicity associated with trastuzumab-based adjuvant chemotherapy for early breast cancer.

Russo G, Cioffi G, Di Lenarda A, Tuccia F, Bovelli D, Di Tano G, Alunni G, Gori S, Faggiano P, Tarantini L. Russo G, et al. Among authors: gori s. Intern Emerg Med. 2012 Oct;7(5):439-46. doi: 10.1007/s11739-012-0794-9. Epub 2012 Jun 20. Intern Emerg Med. 2012. PMID: 22714882

10

Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer.

Natoli C, Vici P, Sperduti I, Grassadonia A, Bisagni G, Tinari N, Michelotti A, Zampa G, Gori S, Moscetti L, De Tursi M, Panebianco M, Mauri M, Ferrarini I, Pizzuti L, Ficorella C, Samaritani R, Mentuccia L, Iacobelli S, Gamucci T. Natoli C, et al. Among authors: gori s. J Cancer Res Clin Oncol. 2013 Jul;139(7):1229-40. doi: 10.1007/s00432-013-1436-y. Epub 2013 Apr 20. J Cancer Res Clin Oncol. 2013. PMID: 23604446 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

433 results

Search Page